ULURU
Open enrollment with a later-stage pipeline tilt
According to ClinicalTrials.gov-derived indexes, ULURU sits in the upper quartile of US sponsors by registered trial count (#2,411 of 15,742 sponsors by registered trial count).
ULURU: 5 sponsored US clinical trials, 2 recruiting.
ULURU sponsors 5 registered US clinical trials on ClinicalTrials.gov, 2 of them currently recruiting, and 2 completed. 1 of these trials are in Phase 3-4 (later-stage) and 0 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Pressure Ulcer, Stage IV, with 1 trials.
Upper-quartile sponsor footprint
ULURU sits in the upper quartile of the sponsor corpus (#2,411 of 15,742 sponsors by registered trial count) - denser than most sponsors, still short of the top-decile hubs.
Open and recent trials
5 total, page 1 of 1
Comparison of Transforming Powder Dressing to NPIAP Recommended Standard of Care Therapies in Stage 2, 3 and 4 Pressure Injuries
NCT05496296
Acute Partial Thickness Burn Study Comparing Transforming Powder Dressing to Standard of Care Dressing
NCT05424354
Diabetic Foot Ulcers-Comparing Transforming Powder to Standard of Care
NCT05046158
Altrazeal™ Versus Aquacel® Ag for Partial Thickness Skin Donor Sites
NCT01062204
Altrazeal Range of Motion Study Comparing With Typical Carboxymethyl
NCT01062191
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 4 | 1 |
Therapeutic Areas
Where ULURU enrollment is open (later-stage tilt)
2 recruiting of 5 indexed (40% open); 2 completed (40%).
Phase mix: 1 late (III/IV) vs 0 early (I/II) (later-stage heavy).
Top condition: Pressure Ulcer, Stage IV (1 trial), 4 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
ULURU: open-pipeline peers nationwide
Peers matched on 5 registered trials and 40% open enrollment, not the therapeutic-area sidebar.
ULURU sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 5 trials (± recruiting share)
- 4YouandMe · 5 trials · 0% recruiting
- Abbott Rapid Dx · 5 trials · 0% recruiting
- Access Business Group · 5 trials · 0% recruiting
- Acera Surgical · 5 trials · 20% recruiting
Sponsors near 40% open enrollment (± trial volume)
- Ad scientiam · 40% recruiting · 5 trials
- Alto Neuroscience · 40% recruiting · 10 trials
- Bonafide Health · 40% recruiting · 5 trials
- Brooks Rehabilitation · 40% recruiting · 5 trials
Related
What to do with this ULURU page
5 registered trials is a research-attention snapshot, not an endorsement of ULURU or any single study.
- 2 of ULURU's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Pressure Ulcer, Stage IV is the condition ULURU studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Pressure Ulcer, Stage IV trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
ULURU pipeline card: 5 registered trials from official public datasets.Report a data error.